Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
Market Cap
$260.69M
P/E Ratio
-2.2
1Y Stock Return
152.74%
1Y Revenue Growth
24.05%
Dividend Yield
0.00%
Price to Book
1.6
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
JRVR | -0.01% | $168.34M | -52.25% | 4.52% |
KNOP | -0.02% | $210.40M | +11.75% | 1.68% |
BK | 0.04% | $56.43B | +65.37% | 2.29% |
CCEC | -0.07% | $1.02B | +28.03% | 3.26% |
ZCMD | -0.07% | $2.80M | -88.67% | 0.00% |
PG | 0.07% | $402.15B | +14.14% | 2.33% |
UUU | -0.09% | $4.97M | -41.89% | 0.00% |
VITL | -0.12% | $1.32B | +142.79% | 0.00% |
LTM | -0.15% | $8.51B | -100.00% | <0.01% |
VST | -0.15% | $52.69B | +349.00% | 0.56% |
LHX | 0.15% | $46.20B | +29.18% | 1.91% |
CIG.C | 0.21% | $2.48B | -3.55% | 0.00% |
HBM | 0.21% | $3.19B | +100.00% | 0.16% |
GAN | 0.22% | $83.39M | +21.19% | 0.00% |
NINE | 0.23% | $49.99M | -42.44% | 0.00% |
MCY | 0.26% | $4.07B | +102.23% | 1.73% |
SPH | -0.28% | $1.15B | +6.07% | 7.25% |
COR | -0.28% | $47.48B | +21.20% | 0.86% |
EEX | 0.31% | $964.17M | -8.83% | 0.63% |
ARQ | 0.33% | $332.89M | +216.80% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HE | 34.34% | $1.82B | -17.47% | 0.00% |
RVNC | 29.55% | $394.43M | -47.99% | 0.00% |
ARCT | 28.03% | $489.20M | -21.27% | 0.00% |
RGP | 27.14% | $276.47M | -41.17% | 6.78% |
ALTO | 26.54% | $106.54M | -39.83% | 0.00% |
JHX | 26.54% | $15.44B | +11.44% | 0.00% |
ENOV | 26.43% | $2.53B | -10.59% | 0.00% |
BANC | 26.41% | $2.70B | +28.94% | 2.49% |
UCB | 26.40% | $3.91B | +35.08% | 2.86% |
PINC | 26.27% | $2.14B | +5.54% | 3.79% |
ATRC | 26.25% | $1.77B | -12.85% | 0.00% |
HASI | 26.20% | $3.29B | +16.65% | 5.90% |
INMD | 26.19% | $1.50B | -21.29% | 0.00% |
QTRX | 26.18% | $424.47M | -53.12% | 0.00% |
FOLD | 26.00% | $2.84B | -11.52% | 0.00% |
SOFI | 25.98% | $15.65B | +114.58% | 0.00% |
HBAN | 25.97% | $25.48B | +60.92% | 3.53% |
BC | 25.94% | $5.25B | +1.60% | 2.11% |
CNS | 25.91% | $5.06B | +77.73% | 2.35% |
AGM | 25.91% | $2.23B | +25.26% | 2.60% |
Yahoo
FREMONT, Calif., November 20, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will participate at the following investor conferences:
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, Personalis ( NASDAQ:PSNL...
Yahoo
Personalis ( NASDAQ:PSNL ) Third Quarter 2024 Results Key Financial Results Revenue: US$25.7m (up 41% from 3Q 2023...
Yahoo
Personalis Inc (PSNL) reports a 41% revenue increase and significant BioPharma growth, while navigating challenges in reimbursement and key partnerships.
Yahoo
Personalis (PSNL) delivered earnings and revenue surprises of -93.94% and 24.40%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
PSNL) on Wednesday reported a loss of $39.1 million in its third quarter. On a per-share basis, the Fremont, California-based company said it had a loss of 64 cents. The provider of contract research and genomic information posted revenue of $25.7 million in the period, surpassing Street forecasts.
Current Value
$3.761 Year Return
Current Value
$3.761 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
WRB | -15.53% | $22.94B | +29.98% | 0.69% |
SIGI | -14.03% | $5.90B | -4.96% | 1.47% |
TRV | -13.79% | $58.86B | +48.10% | 1.59% |
PULM | -13.42% | $19.83M | +202.98% | 0.00% |
LPLA | -13.20% | $23.55B | +38.13% | 0.38% |
SCHL | -12.29% | $682.89M | -38.46% | 3.31% |
TCTM | -12.21% | $8.10M | -42.99% | 0.00% |
RNR | -11.88% | $13.74B | +23.09% | 0.58% |
KLG | -11.26% | $1.48B | +45.15% | 3.71% |
GOGL | -9.63% | $2.39B | +35.11% | 8.40% |
WM | -9.57% | $87.92B | +27.58% | 1.34% |
CX | -9.56% | $8.22B | -20.23% | 0.00% |
EG | -9.50% | $15.92B | -8.98% | 2.02% |
SUNS | -9.48% | $105.89M | +35.31% | 1.37% |
TPST | -8.51% | $37.75M | -77.59% | 0.00% |
PAGP | -8.28% | $3.67B | +16.79% | 0.00% |
QNTM | -8.20% | $9.19M | -94.36% | 0.00% |
MANU | -8.00% | $2.88B | -9.41% | 0.00% |
SOC | -7.84% | $1.93B | +74.70% | 0.00% |
TME | -7.84% | $7.80B | +28.31% | 1.22% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 37.41% | $1.13B | 0.75% |
XBI | 32.82% | $6.58B | 0.35% |
FBT | 32.34% | $1.11B | 0.56% |
PBE | 32.11% | $258.53M | 0.58% |
GNOM | 31.51% | $70.59M | 0.5% |
XPH | 31.35% | $157.87M | 0.35% |
XHE | 31.27% | $213.41M | 0.35% |
FXH | 31.00% | $1.15B | 0.62% |
IBB | 30.93% | $6.66B | 0.45% |
PTH | 30.42% | $143.31M | 0.6% |
IWC | 30.07% | $933.99M | 0.6% |
BATT | 29.54% | $70.90M | 0.59% |
VXF | 29.18% | $21.54B | 0.06% |
BBH | 28.96% | $397.87M | 0.35% |
IPAY | 28.87% | $325.84M | 0.75% |
ERTH | 28.79% | $162.01M | 0.67% |
PBD | 28.77% | $89.54M | 0.75% |
FAN | 28.71% | $163.64M | 0.6% |
KOMP | 28.56% | $2.09B | 0.2% |
PINK | 27.98% | $161.15M | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -0.29% | $40.60M | 0.65% |
DBMF | -0.81% | $1.02B | 0.85% |
TBLL | -0.86% | $1.92B | 0.08% |
KMLM | -0.90% | $353.87M | 0.9% |
GSG | 1.14% | $914.42M | 0.75% |
HDRO | -1.18% | $164.26M | 0.3% |
BSCO | -1.28% | $2.35B | 0.1% |
IBTE | 1.32% | $1.70B | 0.07% |
FTGC | 1.53% | $2.17B | 1.02% |
MINT | 1.65% | $11.62B | 0.35% |
CANE | 1.67% | $17.72M | 0.29% |
BOXX | -1.67% | $4.43B | 0.1949% |
XHLF | 1.89% | $874.27M | 0.03% |
JBBB | 2.12% | $1.26B | 0.49% |
IAK | 2.33% | $760.79M | 0.39% |
TAIL | -2.56% | $67.98M | 0.59% |
CORN | -2.62% | $61.12M | 0.2% |
PHDG | 2.64% | $113.97M | 0.39% |
FLTR | 2.76% | $1.79B | 0.14% |
SEIX | 2.78% | $268.81M | 0.62% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -24.54% | $388.04M | 1.43% |
DBA | -20.53% | $755.88M | 0.93% |
SOYB | -18.73% | $27.32M | 0.22% |
USCI | -15.94% | $185.47M | 1.07% |
EQLS | -13.71% | $76.08M | 1% |
UUP | -13.46% | $309.25M | 0.77% |
USDU | -12.33% | $201.97M | 0.5% |
DBO | -11.73% | $217.57M | 0.77% |
DBE | -10.47% | $50.13M | 0.77% |
VIXY | -10.15% | $195.31M | 0.85% |
COMT | -10.01% | $829.06M | 0.48% |
KCCA | -8.45% | $220.51M | 0.87% |
HIGH | -7.64% | $302.78M | 0.51% |
CLOI | -7.08% | $715.40M | 0.4% |
CTA | -5.82% | $350.27M | 0.78% |
IVOL | -5.17% | $548.70M | 1.02% |
CORN | -2.62% | $61.12M | 0.2% |
TAIL | -2.56% | $67.98M | 0.59% |
BOXX | -1.67% | $4.43B | 0.1949% |
BSCO | -1.28% | $2.35B | 0.1% |